Efficacy of Serologic Marker Screening in Identifying Hepatitis B Virus Infection in Organ, Tissue, and Cell Donors  Dominique Challine, Stéphane Chevaliez,

Slides:



Advertisements
Similar presentations
False negative HBsAg detectionFalse negative HBsAg detection n Is rare in patients with signs of chronic hepatitis B. n May be an issue in low-risk populations,
Advertisements

Evangelos Cholongitas, George V. Papatheodoridis, Andrew K. Burroughs 
Pathogenesis and Treatment of Hepatitis E Virus Infection
Thrombocytopenia With Abnormal Liver Function Tests
Volume 148, Issue 7, Pages e3 (June 2015)
Volume 136, Issue 4, Pages (April 2009)
Investigation of Outbreak of Infections Caused by Salmonella Saintpaul
Les Lang  Gastroenterology  Volume 133, Issue 1, (July 2007)
Volume 132, Issue 3, Pages (March 2007)
Volume 137, Issue 4, Pages (October 2009)
Volume 136, Issue 4, Pages (April 2009)
Les Lang  Gastroenterology  Volume 133, Issue 1, (July 2007)
Pathogenesis and Treatment of Hepatitis E Virus Infection
Christoph Lübbert, Babett Holler  Gastroenterology 
Volume 141, Issue 4, Pages (October 2011)
Volume 144, Issue 5, Pages (May 2013)
Covering the Cover Gastroenterology
Effectiveness of Hepatitis B Treatment in Clinical Practice
Is HCV Infection a Neurologic Disorder?
Outcomes Among Living Liver Donors
Lost in Inflammation: The Functional Conversion of Regulatory T Cells in Acute Hepatitis A Virus Infection  Tobias Boettler, Robert Thimme  Gastroenterology 
Volume 134, Issue 5, Pages (May 2008)
Ira J. Fox, Stephen C. Strom  Gastroenterology 
Introduction The American Journal of Medicine
Clinical Challenges and Images in GI
Volume 155, Issue 4, Pages (October 2018)
Volume 135, Issue 4, Pages (October 2008)
Volume 133, Issue 5, Pages (November 2007)
Evangelos Cholongitas, George V. Papatheodoridis, Andrew K. Burroughs 
American Gastroenterological Association Institute Technical Review on Prevention and Treatment of Hepatitis B Virus Reactivation During Immunosuppressive.
Volume 150, Issue 4, Pages (April 2016)
Volume 154, Issue 4, Pages (March 2018)
TLL1 rs Increases the Risk of Fibrosis Progression in Caucasian Patients With Chronic Hepatitis C  Miya John, Mayada Metwally  Gastroenterology 
Yasuhiko Sugawara, Masatoshi Makuuchi 
Volume 155, Issue 5, Pages e2 (November 2018)
Jean-Michel Pawlotsky  Gastroenterology 
Volume 127, Issue 5, Pages (November 2004)
Volume 136, Issue 7, Pages (June 2009)
Jean–Michel Pawlotsky, Stéphane Chevaliez, John G. McHutchison 
A. Sidney Barritt, Michael W. Fried  Gastroenterology 
Volume 145, Issue 1, Pages (July 2013)
Volume 142, Issue 6, Pages e3 (May 2012)
Impact of New Hepatitis C Treatments in Different Regions of the World
Occupational transmission of hepatitis C virus resulting from use of the same supermarket meat slicer  L. Bocket, S. Chevaliez, N. Talbodec, A. Sobaszek,
Rafael Esteban, Maria Buti  Gastroenterology 
Brendan Campbell, Benny Liu, Taft Bhuket, Robert J. Wong 
Ashwin N. Ananthakrishnan, David Lieberman  Gastroenterology 
Volume 148, Issue 3, Pages (March 2015)
Covering the Cover Gastroenterology
Volume 135, Issue 4, Pages (October 2008)
Shivan J. Mehta, Kimberly A. Forde  Gastroenterology 
Jeremy P. Dwyer, Patrick Hosking, John Lubel  Gastroenterology 
Pathogenesis and Treatment of Hepatitis E Virus Infection
The Rise and Fall (and Rise?) of Endoscopic Anti-Reflux Procedures
Alan Bonder, MD, Nezam H. Afdhal, MD 
The Dawning of a New Editorial Board for Gastroenterology
Volume 141, Issue 4, Pages (October 2011)
Volume 132, Issue 3, Pages (March 2007)
Volume 151, Issue 4, Pages (October 2016)
Thrombocytopenia With Abnormal Liver Function Tests
Volume 156, Issue 3, Pages (February 2019)
Volume 155, Issue 6, Pages (December 2018)
Volume 139, Issue 6, Pages e1 (December 2010)
Volume 138, Issue 6, Pages (May 2010)
Molecular epidemiology of hepatitis B virus in Iran
Volume 135, Issue 5, Pages (November 2008)
Reinvesting in US Biomedical Research—The Time is Now
Controversies in Liver Transplantation for Hepatitis C
The Results of Phase III Clinical Trials With Telaprevir and Boceprevir Presented at the Liver Meeting 2010: A New Standard of Care for Hepatitis C Virus.
Craig Lammert, Megan Comerford, Joshua Love  Gastroenterology 
Presentation transcript:

Efficacy of Serologic Marker Screening in Identifying Hepatitis B Virus Infection in Organ, Tissue, and Cell Donors  Dominique Challine, Stéphane Chevaliez, Jean–Michel Pawlotsky  Gastroenterology  Volume 135, Issue 4, Pages 1185-1191 (October 2008) DOI: 10.1053/j.gastro.2008.07.011 Copyright © 2008 AGA Institute Terms and Conditions

Figure 1 Amino acid sequence alignment of the major hydrophilic region (in squares) HBsAg in the 29 donors in whom the full-length preS1–preS2-S gene could be amplified, including 23 donors with detectable HBsAg, 2 donors with isolated anti-HBc antibodies, 3 donors with both HBsAg and anti-HBs antibodies, and the donor with isolated anti-HBs antibodies. The “a” determinant sequence (amino acids 124–147) is underlined at the top. The sequences are aligned relative to an HBV genotype A prototype sequence, together with prototype sequences of genotypes A–H. The donors' genotypes are indicated in parentheses. Amino acid positions previously reported to bear substitutions associated with HBsAg detection failure in HBV-DNA–positive patients are shown in gray. Amino acid substitutions observed at these positions in the donors of this study are shown in bold letters. Gastroenterology 2008 135, 1185-1191DOI: (10.1053/j.gastro.2008.07.011) Copyright © 2008 AGA Institute Terms and Conditions